FDA Clears Withings' Smart Watch For Detecting AF and Measuring Blood Oxygen

The French company is promoting its ScanWatch as the first wearable device to receive FDA clearance for both atrial fibrillation detection through medical grade ECG and measuring SpO2 levels from the wrist.

• Source: Withings

More from Approvals

More from Policy & Regulation